Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0, while the study record content appears unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T13:10:10.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner was added announcing the NIH website transition and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.7%
    Check dated 2026-10-24T12:41:29.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:11:04.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T13:45:35.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the study's record history, and the previous revision (v3.6.6) was removed, signaling an updated submission to the record.
    Difference
    0.1%
    Check dated 2026-09-19T19:01:43.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    No additions or deletions are reported for this page.
    Difference
    0.1%
    Check dated 2026-09-05T20:04:53.000Z thumbnail image

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.